Correct Answer: B

Rationale: Clients taking warfarin should report any signs of bleeding to their healthcare provider as it can indicate excessive anticoagulation. Bleeding can be a serious side effect of warfarin and should be promptly addressed by a healthcare provider to prevent complications.

Correct Answer: C

Rationale: When a patient is being treated with Lithium, a life-threatening side effect to watch out for is seizures. Seizures are serious and necessitate prompt medical intervention to ensure the patient's safety and well-being.

Correct Answer: A

Rationale: Filgrastim is a medication used to stimulate the production of white blood cells, specifically neutrophils, to increase the white blood cell count. This increase in white blood cells helps reduce the risk of infections in clients with neutropenia, a condition characterized by low levels of neutrophils.

Correct Answer: D

Rationale: The correct laboratory test to monitor the therapeutic effect of warfarin is the PT/INR. Warfarin affects blood clotting, and the PT/INR levels indicate the effectiveness of the medication in preventing clot formation. Therefore, monitoring PT/INR levels helps ensure that the client is within the therapeutic range and is protected from potential complications related to clotting.

Correct Answer: A

Rationale: Correct. Aluminum hydroxide is known to cause constipation as a common side effect. Instructing the client about this potential adverse effect is important for their awareness and management. Monitoring and managing constipation can help improve the client's comfort and overall treatment experience.